loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Jqc (huayin) Pharmaceutical Co.,ltd

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 2-ethylhexyl salicylate (1)

02 Ammonium salicylate (1)

03 Amyl salicylate (1)

04 Asprin (1)

05 Benzoic Acid (1)

06 Bismuth Subsalicylate (1)

07 Butyl salicylate (1)

08 Carbaspirin Calcium (1)

09 Ethyl salicylate (1)

10 Magnesium Salicylate (1)

11 Methyl Salicylate (1)

12 Octyl salicylate (1)

13 Salicyclic acid (1)

14 Sodium Salicylate (1)

15 glycol salicylate (1)

16 salicylamide (1)

filter

01 JQC (Huayin) Pharmaceutical Co.,Ltd (16)

filter

01 China (16)

URL Supplier Web Content
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the curre...
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the current net capital is nearly 150 million RMB. The company passed GMP issued by the State Food and Drug Administration (SFDA) in 2004, 2010 and 2015.Meanwhile, our quality system passed US FDA inspection In January 26, 2013, and NDC code was registered in D&B.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the curre...
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the current net capital is nearly 150 million RMB. The company passed GMP issued by the State Food and Drug Administration (SFDA) in 2004, 2010 and 2015.Meanwhile, our quality system passed US FDA inspection In January 26, 2013, and NDC code was registered in D&B.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the curre...
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the current net capital is nearly 150 million RMB. The company passed GMP issued by the State Food and Drug Administration (SFDA) in 2004, 2010 and 2015.Meanwhile, our quality system passed US FDA inspection In January 26, 2013, and NDC code was registered in D&B.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the curre...
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the current net capital is nearly 150 million RMB. The company passed GMP issued by the State Food and Drug Administration (SFDA) in 2004, 2010 and 2015.Meanwhile, our quality system passed US FDA inspection In January 26, 2013, and NDC code was registered in D&B.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the curre...
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the current net capital is nearly 150 million RMB. The company passed GMP issued by the State Food and Drug Administration (SFDA) in 2004, 2010 and 2015.Meanwhile, our quality system passed US FDA inspection In January 26, 2013, and NDC code was registered in D&B.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the curre...
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the current net capital is nearly 150 million RMB. The company passed GMP issued by the State Food and Drug Administration (SFDA) in 2004, 2010 and 2015.Meanwhile, our quality system passed US FDA inspection In January 26, 2013, and NDC code was registered in D&B.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the curre...
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the current net capital is nearly 150 million RMB. The company passed GMP issued by the State Food and Drug Administration (SFDA) in 2004, 2010 and 2015.Meanwhile, our quality system passed US FDA inspection In January 26, 2013, and NDC code was registered in D&B.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the curre...
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the current net capital is nearly 150 million RMB. The company passed GMP issued by the State Food and Drug Administration (SFDA) in 2004, 2010 and 2015.Meanwhile, our quality system passed US FDA inspection In January 26, 2013, and NDC code was registered in D&B.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the curre...
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the current net capital is nearly 150 million RMB. The company passed GMP issued by the State Food and Drug Administration (SFDA) in 2004, 2010 and 2015.Meanwhile, our quality system passed US FDA inspection In January 26, 2013, and NDC code was registered in D&B.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the curre...
Founded in 2002, JQC (Huayin) Pharmaceutical Co., Ltd. is a private pharmaceutical enterprise, that focus in Salicylic acid series API & intermediates production and research development. The predecessor was a state-owned corporation-“Northwest Second Synthesis Pharmaceutical”. The company’s register capital is 11.18 million RMB and the current net capital is nearly 150 million RMB. The company passed GMP issued by the State Food and Drug Administration (SFDA) in 2004, 2010 and 2015.Meanwhile, our quality system passed US FDA inspection In January 26, 2013, and NDC code was registered in D&B.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY